Practice Management News

People who increased their alcohol consumption or began binge drinking during the beginning of the pandemic had greater odds of developing mental health disorders, according to findings published in Alcohol and Alcoholism.

A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.

Biogen Inc. has reported promising data from a phase 1b trial of BIIB080, an investigational antisense oligonucleotide therapy that reduced soluble tau protein in cerebrospinal fluid in patients with early Alzheimer’s disease.

The federal Physician Self-Referral Law — aka the Stark Law — is a federal statute designed to curb unnecessary utilization of certain health care services.

The proportion of family physicians who reported working collaboratively with a behavioral health professional increased from 34.8% in 2017 to 43% in 2021, a recent study found.

At the end of 2022, Congress passed a massive 4,155-page spending package that included SECURE Act 2.0, which provided numerous improvements to retirement savings and distribution rules.

The American Psychiatric Association has recommended the Drug Enforcement Administration ensure access to buprenorphine and other controlled drugs through telehealth to combat the opioid epidemic and the national mental health crisis.

Medical organizations are sounding the alarm after a federal judge ruled that it is unconstitutional to require insurers and health plans to cover preventive services recommended by the U.S. Preventive Services Task Force at no cost.

The prevalence of psychological comorbidities among patients with coxarthrosis increased by 37.8% — and by 17.9% for those with gonarthrosis — between 2009 and 2019, according to German data published in Scientific Reports.

Alzheon Inc. has announced positive interim findings from an ongoing phase 2 study evaluating ALZ-801, an investigational disease-modifying treatment for Alzheimer’s disease.